Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hai-Bin Shi is active.

Publication


Featured researches published by Hai-Bin Shi.


PLOS ONE | 2014

Sorafenib Combined with Transarterial Chemoembolization versus Transarterial Chemoembolization Alone for Advanced-Stage Hepatocellular Carcinoma: A Propensity Score Matching Study

Hao Hu; Zhenhua Duan; Xiaoran Long; Yancu Hertzanu; Hai-Bin Shi; Sheng Liu; Zheng-Qiang Yang

Aims The purpose of the present study was to compare the efficacies of transarterial chemoembolization (TACE) combined with sorafenib versus TACE monotherapy for treating patients with advanced hepatocellular carcinoma (HCC). Methods We enrolled 321 patients and selected 280 with advanced HCC (Barcelona Clinic Liver Cancer stage C) who underwent TACE therapy between February 2009 and February 2013. TACE alone (monotherapy group) was administered to 198 patients (70.7%), and the remaining 82 (29.3%) underwent repeat combined TACE and sorafenib therapy (combined group). To minimize selection bias, these latter 82 patients were matched using propensity-score matching at a 1∶2 ratio with 164 patients who received TACE monotherapy. The primary endpoints were overall survival (OS) and related subgroup analysis. The secondary endpoints were time to progression (TTP) and treatment-related adverse events. Results Of the respective patients in the combined and monotherapy groups, 64.6% and 49.2% had vascular invasion, 87.8% and 91.1% had extrahepatic metastasis, and 54.3% and 47.1% had both. In the propensity-score–matched cohort, the OS survival of the combined group was significantly higher compared with the monotherapy group (7.0 months vs. 4.9 months, respectively, Pu200a=u200a0.003). The TTP was significantly longer in the combined group (2.6 months vs. 1.9 months, respectively, Pu200a=u200a0.001). Subgroup analysis showed that the outcomes of patients with advanced HCC without main portal vein invasion who were treated with combined therapy were significantly better compared with those who received monotherapy (P<0.05). Univariate and subsequent multivariate analyses revealed that the addition of sorafenib was an independent predictor of favorable OS and TTP (adjusted hazard ratios, 0.63 and 0.62, respectively; P<0.05 for both). Conclusion Sorafenib plus TACE was more effective than TACE monotherapy for treating patients with advanced HCC without main portal vein invasion. Future trials with larger samples are required to validate these preliminary findings.


Journal of Neuroscience Methods | 2012

A novel embolic stroke model resembling lacunar infarction following proximal middle cerebral artery occlusion in beagle dogs.

Sheng Liu; Wei-Xing Hu; Qing-Quan Zu; Shan-Shan Lu; Xiao-Quan Xu; Lei Sun; Wei-Zhong Zhou; Hai-Bin Shi

It is estimated that lacunar infarcts account for 25% of all ischemic strokes, but its exact etiology is still on debating. The existing controversies include whether the embolisms can indeed cause lacunar stroke in humans or animal models. We hypothesized that lacunar infarction can be induced by the proximal middle cerebral artery (MCA) segmental occlusion involving the orifices of lenticulostriate arteries in animal models, which have abundant distal cerebral collateral anastomosis. Our work here establishes a proximal MCA occlusion model using thrombi (autologous blood clots about 1.7 mm in diameter and 5 mm in length) in 8 beagle dogs, evaluates the progression of ischemic lesions at 30 min interval within 6 h after embolization using the diffusion weighted imaging (DWI), and discusses the potential mechanisms of lacunar infarction. Our results indicate that the left proximal MCAs can be successfully occluded in all dogs using interventional single-thrombus method. The small solitary or multiple ischemic lesions shown in DWI were observed in the deep brain area, with the mean detecting time of 1.21 ± 0.45 h using DWI and diameter of 6.62 ± 0.60mm in 6h-DWI after procedure. In conclusion, our method established an ischemic model which can recapitulate the radiologic and histologic changes in lacunar infarcts, suggesting that emboli can cause lacunar infarcts in animal model.


CardioVascular and Interventional Radiology | 2014

Prophylactic Uterine Artery Embolization Assisted Cesarean Section for the Prevention of Intrapartum Hemorrhage in High-Risk Patients

Qun Li; Zheng-Qiang Yang; Wasif Mohammed; Yao-Liang Feng; Hai-Bin Shi; Xin Zhou

PurposeTo evaluate the safety and efficacy of prophylactic uterine artery embolization (UAE)-assisted cesarean section for the prevention of intrapartum hemorrhage.Materials and MethodsTwelve consecutive pregnant women (mean age 31xa0years; range 25–38) with uterine scarring and placenta previa and/or placenta accreta underwent UAE in conjunction with cesarean section to prevent intrapartum hemorrhage. For UAE, the left uterine artery was catheterized prophylactically under fluoroscopic guidance before the cesarean section incision was made. After the infant had been delivered, bilateral UAE was performed with the placenta still in situ. After successful bilateral UAE, the placenta was detached from the uterine wall.ResultsTechnical success was achieved in all 12 cases. Ten patients retained their uterus, and the other 2 underwent hysterectomy. The mean operative blood loss was 1,391xa0mL (range 600–3,600xa0mL). The total mean fluoroscopy time and mean absorbed dose (air kerma) were 9xa0min 40xa0s (range 4xa0min 35xa0s–15xa0min 24xa0s) and 91.79xa0mGy (range 30.2–171), respectively. The average fetal fluoroscopy time was 1xa0min 42xa0s (range 41xa0s to 3xa0min 16xa0s) with an average X-ray dose of 17.66xa0mGy (range 6.04–23.90).ConclusionUAE-assisted cesarean section is safe and effective in the prevention of intrapartum hemorrhage in patients with uterine scarring and/or placental abnormalities.


Journal of Stroke & Cerebrovascular Diseases | 2014

Hypertension Increases the Risk of Cerebral Microbleed in the Territory of Posterior Cerebral Artery: A Study of the Association of Microbleeds Categorized on a Basis of Vascular Territories and Cardiovascular Risk Factors

Zhenyu Jia; Wasif Mohammed; Yiru Qiu; Xunning Hong; Hai-Bin Shi

BACKGROUNDnIt has been suggested that the etiology of cerebral microbleeds (CMBs) differs according to their location in the brain, with lobar microbleeds being caused by cerebral amyloid angiopathy and deep or infratentorial microbleeds resulting from hypertension and atherosclerosis. We hypothesized that there were associations between cerebral arterial branches, cardiovascular risk factors, and the occurrence of CMBs. We examined these relationships in the current study.nnnMETHODSnThree hundred ninety-three patients with CMBs were analyzed in this study. The CMBs were listed according to the various arterial territories, and these were assessed for their relationship with cardiovascular risk factors, markers of small vessel disease, and their presence and location using multiple logistic regression.nnnRESULTSnSystolic blood pressure had a significant association with CMBs in the territory of the posterior cerebral artery and the deep and infratentorial locations. The presence of lacunar infarcts, hemorrhage, and white matter changes were associated with CMBs in nearly all arterial territories.nnnCONCLUSIONSnHypertension increases the risk of microbleeds in the territory of the posterior cerebral artery and the deep and infratentorial locations. Cerebral amyloid angiopathy may be responsible for the microbleeds in the lobar area of brain.


CardioVascular and Interventional Radiology | 2011

Massive Pulmonary Embolism: Treatment with the Rotarex Thrombectomy System

Sheng Liu; Hai-Bin Shi; Jianping Gu; Zheng-Qiang Yang; Liang Chen; Wensheng Lou; Xu He; Wei-Zhong Zhou; Chun-Gao Zhou; Lin-Bo Zhao; Jin-Guo Xia; Lin-Sun Li

This study was designed to evaluate the efficacy and safety of percutaneous mechanical thrombectomy (PMT) for acute massive pulmonary embolism (PE). Fourteen patients (8 men, 6 women) with a mean age of 55.4 (range, 38–71) years with acute massive PE were initially diagnosed by computed tomography (CT) and confirmed by pulmonary angiography. All patients presented with acute PE symptoms and hemodynamic compromise. Each patient was treated with Straub Rotarex thrombectomy device and five patients received additional thrombolysis. Technique success and clinical improvement were achieved in all patients without major complications. The mean pulmonary artery pressure (PAP) decreased from 37.6xa0±xa06.6 to 29xa0±xa06.4xa0mmHg (Pxa0<xa00.01) after PMT. Partial arterial pressures of O2 (PaO2) increased from 61.1xa0±xa09.2 to 88xa0±xa05.1xa0mmHg (Pxa0<xa00.01). The Miller index was 0.67xa0±xa00.11 and 0.37xa0±xa00.13 (Pxa0<xa00.01), respectively, before and after PMT (Pxa0<xa00.01). Eleven patients had no recurrence of PE on a mean follow-up of 28.3xa0months, whereas the other three patients were lost to follow-up. The preliminary experience in our series suggests that the Straub Rotarex thrombectomy device, which has been utilized in peripheral arteries, also is useful for the treatment of acute massive PE.


Neurological Sciences | 2014

Comparative study of the relative signal intensity on DWI, FLAIR, and T2 images in identifying the onset time of stroke in an embolic canine model.

Xiao-Quan Xu; Qiguang Cheng; Qing-Quan Zu; Shan-Shan Lu; Jing Yu; Ye Sheng; Hai-Bin Shi; Sheng Liu

In acute stroke magnetic resonance imaging, many attempts have been made to identify the onset time of ischemic events using the simply quantitative judgment of relative signal intensity (rSI) from various MR images. However, no uniform opinion has been achieved broadly till now. The controversy might derive from the potential patients’ selection bias of clinical retrospective study, the discrepant MR parameters, and the various sample sizes among different studies. Thus, we evaluated the temporal change of the relative DWI signal intensity (rDWI), relative ADC value (rADC), relative FLAIR signal intensity (rFLAIR), and relative T2 signal intensity (rT2), and further compare their diagnostic value in identifying the hyperacute lesions based on our embolic canine model with clear onset time. Twenty ischemic models were successfully established. All rSI values were linearly correlated to time with significance until 24xa0h after model establishment (Pxa0<xa00.05). Paired comparison of ROC curves showed that significant difference was found between rADC and other three rSIs (Pxa0<xa00.0001). However, no significant difference was found among rDWI, rT2 and rFLAIR. Our results indicated that rDWI, rFLAIR and rT2 may be helpful to predict the onset time of ischemic events with the similar diagnostic value. However, the rADC does not have comparable predictive value in our embolic canine model.


Laboratory Investigation | 2013

An endovascular canine stroke model: middle cerebral artery occlusion with autologous clots followed by ipsilateral internal carotid artery blockade

Qing-Quan Zu; Sheng Liu; Xiao-Quan Xu; Shan-Shan Lu; Lei Sun; Hai-Bin Shi

Stroke is one of the leading causes of death worldwide and the main reason for long-term disability. An appropriate animal model of stroke is urgently required for understanding the exact pathophysiological mechanism of stroke and testing any new therapeutic regimen. Our work aimed to establish a canine stroke model occluding the middle cerebral artery (MCA) and blocking the ipsilateral internal carotid artery (ICA), and to assess the infarct lesions by magnetic resonance imaging. The stroke model was generated by injecting two autologous clots into each MCA, followed by 2-h ipsilateral ICA blockade (ilICAB) using a catheter in 15 healthy adult beagles. Outcome measurements included 24-h and 7-day postocclusion T2-weighted imaging (T2WI)-based infarct volume calculation. In addition, pial collateral score, canine neurobehavioral score and histopathologic results were documented. Out of 15 dogs, 12 with successful MCA occlusion (MCAO) and ilICAB survived 7 days without complications or casualties and MCA were reperfused at 7 days after occlusion. High signal intensity in the basal ganglia and cerebral cortex on T2WI was initially observed in each dog at 6u2009h after the procedure. The mean percentage hemispherical infarct volume corrected for edema in all dogs on T2WI at 24u2009h after occlusion was 12.99±1.57%, and the degree of variability was 12.08%. The infarct volumes at 24u2009h after occlusion correlated with pial collateral scores and canine neurobehavioral scores well. This canine stroke model with combined MCAO and ilICAB reported here were proven to be highly feasible and reproducible.


World Journal of Gastroenterology | 2013

Transarterial embolization for massive gastrointestinal hemorrhage following abdominal surgery

Chun-Gao Zhou; Hai-Bin Shi; Sheng Liu; Zheng-Qiang Yang; Lin-Bo Zhao; Jin-Guo Xia; Wei-Zhong Zhou; Lin-Sun Li

AIMnTo evaluate the clinical results of angiography and embolization for massive gastrointestinal hemorrhage after abdominal surgery.nnnMETHODSnThis retrospective study included 26 patients with postoperative hemorrhage after abdominal surgery. All patients underwent emergency transarterial angiography, and 21 patients underwent emergency embolization. We retrospectively analyzed the angiographic features and the clinical outcomes of transcatheter arterial embolization.nnnRESULTSnAngiography showed that a discrete bleeding focus was detected in 21 (81%) of 26 patients. Positive angiographic findings included extravasations of contrast medium (n = 9), pseudoaneurysms (n = 9), and fusiform aneurysms (n = 3). Transarterial embolization was technically successful in 21 (95%) of 22 patients. Clinical success was achieved in 18 (82%) of 22 patients. No postembolization complications were observed. Three patients died of rebleeding.nnnCONCLUSIONnThe positive rate of angiographic findings in 26 patients with postoperative gastrointestinal hemorrhage was 81%. Transcatheter arterial embolization seems to be an effective and safe method in the management of postoperative gastrointestinal hemorrhage.


Journal of Clinical Neurology | 2013

Follow-up of 58 traumatic carotid-cavernous fistulas after endovascular detachable-balloon embolization at a single center.

Xiao-Quan Xu; Sheng Liu; Qing-Quan Zu; Lin-Bo Zhao; Jin-Guo Xia; Chun-Gao Zhou; Wei-Zhong Zhou; Hai-Bin Shi

Background and Purpose This study evaluated the clinical value of detachable-balloon embolization for traumatic carotid-cavernous fistula (TCCF), focusing on the frequency, risk factors, and retreatment of recurrence. Methods Fifty-eight patients with TCCF underwent transarterial detachable-balloon embolization between October 2004 and March 2011. The clinical follow-up was performed every 3 months until up to 3 years postprocedure. Each patient was placed in either the recurrence group or the nonrecurrence group according to whether a recurrence developed after the first procedure. The relevant factors including gender, fistula location, interval between trauma and the interventional procedure, blood flow in the carotid-cavernous fistula, number of balloons, and whether the internal carotid artery (ICA) was sacrificed were evaluated. Results All 58 TCCFs were successfully treated with transarterial balloon embolization, including 7 patients with ICA sacrifice. Recurrent fistulas occurred in seven patients during the follow-up period. Univariate analysis indicated that the interval between trauma and the interventional procedure (p=0.006) might be the main factor related to the recurrence of TCCF. The second treatments involved ICA sacrifice in two patients, fistula embolization with balloons in four patients, and placement of a covered stent in one patient. Conclusions Detachable balloons can still serve as the first-line treatment for TCCFs and recurrent TCCFs despite having a nonnegligible recurrence rate. Shortening the interval between trauma and the interventional procedure may reduce the risk of recurrence.


CardioVascular and Interventional Radiology | 2013

Transarterial embolization with cyanoacrylate for severe arterioportal shunt complicated by hepatocellular carcinoma.

Hai-Bin Shi; Zheng-Qiang Yang; Sheng Liu; Wei-Zhong Zhou; Chun-Gao Zhou; Lin-Bo Zhao; Jin-Guo Xia; Lin-Sun Li

PurposeTo evaluate the efficacy and safety of cyanoacrylate glue embolization in the treatment of severe arterioportal shunt (APS) presenting with hepatofugal portal venous flow in hepatocellular carcinoma (HCC) patients.Materials and MethodsBetween July 2000 and January 2010, 27 HCC patients with severe APS presenting with hepatofugal portal venous flow underwent transarterial angiography and treatment. Among them, four patients were excluded from the study. Twelve patients underwent transarterial chemoperfusion and embolization of APS with cyanoacrylate glue between January 2006 and January 2010 (Emb group), and the other 11 patients undergoing only transarterial chemoperfusion without embolization of APS between July 2000 and December 2005 served as a control group (non-Emb group). The change of APS, survival rates, and procedure related complications were analyzed.ResultsIn the Emb group, APS was improved in all of the 12 patients after initial glue embolization; long-term APS improvement with hepatopetal portal flow was achieved in 80xa0% (8 of 10) patients who underwent follow-up angiography. Survival rates in the Emb group were 67xa0% at 6xa0months, 33xa0% at 1xa0year, and 8xa0% at 2xa0years, whereas those in the non-Emb group were 0xa0% at 6xa0months (Pxa0<xa00.05). Median survival time in the Emb group was 275xa0days, which was longer than that of 107xa0days in the non-Emb group (Pxa0=xa00.001). There were no major complications in both groups.ConclusionThe preliminary experience suggests that glue embolization may be an effective and safe therapy in the management of severe APS accompanied by HCC and also improve patient survival.

Collaboration


Dive into the Hai-Bin Shi's collaboration.

Top Co-Authors

Avatar

Sheng Liu

Nanjing Medical University

View shared research outputs
Top Co-Authors

Avatar

Lin-Bo Zhao

Nanjing Medical University

View shared research outputs
Top Co-Authors

Avatar

Chun-Gao Zhou

Nanjing Medical University

View shared research outputs
Top Co-Authors

Avatar

Jin-Guo Xia

Nanjing Medical University

View shared research outputs
Top Co-Authors

Avatar

Wei-Zhong Zhou

Nanjing Medical University

View shared research outputs
Top Co-Authors

Avatar

Zheng-Qiang Yang

Nanjing Medical University

View shared research outputs
Top Co-Authors

Avatar

Qing-Quan Zu

Nanjing Medical University

View shared research outputs
Top Co-Authors

Avatar

Xiao-Quan Xu

Nanjing Medical University

View shared research outputs
Top Co-Authors

Avatar

Lin-Sun Li

Nanjing Medical University

View shared research outputs
Top Co-Authors

Avatar

Hao Hu

Nanjing Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge